Vanguard Group Inc Co Diagnostics, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,733,245 shares of CODX stock, worth $658,633. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,733,245
Previous 1,778,182
2.53%
Holding current value
$658,633
Previous $551,000
11.98%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CODX
# of Institutions
38Shares Held
5.08MCall Options Held
65.5KPut Options Held
0-
Private Advisory Group LLC Redmond, WA1.18MShares$449,0200.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny561KShares$213,1880.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$190,7690.0% of portfolio
-
Geode Capital Management, LLC Boston, MA320KShares$121,5960.0% of portfolio
-
Jane Street Group, LLC New York, NY166KShares$63,1760.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $12.8M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...